1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with gefitinib in 1 studies
Studies (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Trials (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Recent Studies (post-2010) (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) |
---|---|---|---|---|---|
30 | 0 | 23 | 5,231 | 566 | 2,919 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, J; Fan, XX; He, JX; Huang, J; Huang, M; Jiang, ZB; Kam, RK; Leung, EL; Liu, L; Michelangeli, F; Mujtaba, T; Wong, VK; Xiao, DK; Xu, SW; Xue, WW; Yao, XJ; Zhou, YL | 1 |
1 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and gefitinib
Article | Year |
---|---|
(Z)3,4,5,4'-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level.
Topics: Adenylate Kinase; Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Endoplasmic Reticulum Stress; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Quinazolines; Stilbenes | 2015 |